INTRODUCTION
The thyroid hormone tri-iodothyronine (T3) has profound effects on numerous enzymes involved in hepatic metabolism [1] . Phosphoenolpyruvate carboxykinase (PEPCK) controls the initiating and rate-limiting step in the pathway ofgluconeogenesis [2] . PEPCK abundance and gluconeogenesis are elevated in the hyperthyroid state [3] . Transcription of the PEPCK gene is increased in hyperthyroid rats and decreased in hypothyroid animals [4] . In isolated hepatocytes, T3 induces PEPCK expression and greatly potentiates the induction by cyclic AMP (cAMP) [5] . In addition, transcription of the PEPCK gene is stimulated by glucagon (via cAMP), glucocorticoids and retinoic acid, whereas it is inhibited by insulin [6] [7] [8] [9] . Sequences in the promoter of the PEPCK gene involved in these hormone responses have been identified. A region in the PEPCK promoter from -332 to -308 was identified which confers T3 responsiveness to the PEPCK promoter [10] . A consensus cAMPresponsive element (CRE) (-90 to -82) has been defined that can bind the cAMP-responsive-element-binding protein (CREB) and members of the CCAAT-enhancer-binding protein (C/EBP) family [11] [12] [13] . An upstream region called P3(I) (-250 to -234) is required for cAMP and T3 responsiveness as well as for directing expression of PEPCK to the liver [10, 11, 14] . This element binds C/EBPs [12, 13] . Members of the C/EBP family are involved in directing expression of liver-specific genes and adipocyte differentiation [15] [16] [17] . In addition, C/EBPa has been proposed to be a regulator of genes encoding proteins involved in energy metabolism [18] . T3 mediates its effects through a nuclear T3 receptor (TR) which has two isoforms, a and , [19] . The liver contains primarily the fl-isoform [19] . An idealized T3-responsive element (TRE) has been defined which consists of two direct repeats of an AGGTCA motif separated by 4 bp (DR4) [20] . This element comprises part of the 3-4-5 rule in which direct repeats of the AGGTCA sequence separated by 3, 4 and 5 bp form hormoneresponse elements for vitamin D, T3 and retinoic acid respectively [20] . However, TR can bind other motifs including palindromes and single repeats [21, 22] . In the natural TREs that have been described, the AGGTCA sequence has been loosely conserved [23] . In addition, the nucleotides flanking the AGGTCA motif may contribute to TR binding [22] .
Although TR can bind to its DNA-recognition site as a monomer or a homodimer, it binds with far greater affinity as a heterodimer with the retinoid X receptor (RXR) [24] . RXRs are composed of several family members which are present in most tissues and cell lines [19] . RXRa is expressed most abundantly in the liver [24] . RXR forms high-affinity DNA-binding heterodimers with several additional receptors, including the vitamin D receptor, the retinoic acid receptor (RAR) and the peroxisomal proliferator receptor (PPAR) [19] .
The goal of our studies was to characterize further the sequences and proteins involved in T3 stimulation of PEPCK transcription. Our idealized TRE suggesting that in vivo T3 stimulates transcription through a variety of sequences. Our data show that T3 induction of PEPCK transcription involves interactions between TR bound to TRE and a C/EBP on the P3(I) element of the PEPCK promoter. The interaction of the liganded TR with other transcription factors may become a more widely described phenomenon as more T3-responsive genes are examined.
MATERIALS AND METHODS Preparatlon of recombinant proteins In Escherichia coli
The full-length cDNA of rat TR,8 [25] was ligated into the FlagMac expression vector, which contains the Flag recognition peptide at the N-terminus (IBI). This protein was expressed in the M15pREP E. coli strain. After induction for 1.5 h with 1.0 mM isopropyl f8-D-thiogalactopyranoside, the E. coli were harvested and lysed by repeated freeze-thawing. The particulate material was removed by centrifugation at 175000 g (50000 rev./min) in a Ti8O rotor. The Fl-TR,f was bound to Flag antibody linked to resin in buffer containing 10 mM Tris/HCl, pH 7.4, 150 mM NaCl, 10% glycerol and protease inhibitors. After extensive washing of the resin, the Fl-TR,6 was eluted with a competitor peptide as described by the manufacturer (IBI). The cDNA of RXRa [24] was ligated into the vector, pQE9, which contains a six-amino acid histidine tag at the Nterminus (Quiagen). An NcoI site at amino acid 27 and a HindlIl site in the 3' untranslated region of RXRa were used to subclone into pQE9. The His-RXRa expression vector was transformed into MI 5pREP cells. After induction with 1.0 mM isopropyl fl-D-thiogalactopyranoside, the E. coil were lysed by freezethawing in 10 mM Tris/HCl, pH 7.5, containing 400 mM KCl, 1 mM 2-mercaptoethanol, 20 % glycerol and protease inhibitors. Further purification was performed by binding the RXRa to a nickel-affinity resin (Quiagen) in the lysis buffer. After washing ofthe resin with lysis buffer containing 1, 10 or 40 mM imidazole, the His-RXRa vector was eluted from the resin with the same buffer containing 200 mM imidazole [26] . Proteins were isolated from rat liver nuclei as described previously [27] .
Gel mobility assays
Gel mobility assays were conducted on 5 % non-denaturing acrylamide gels in 22 mM Tris/190 mM glycine at 4°C [28] . Double-stranded oligomers were labelled with Klenow enzyme and [a-32P]dCTP [29] . The binding reactions were performed at room temperature in buffer containing 10% glycerol, 80 mM KCl, 25 mM Tris/HCl, pH 7.4, 1 mM EDTA and 1 mM dithiothreitol. Each binding reaction mixture contained 2.5,ug of poly(dI-dC) as non-specific competitor and proteins as indicated. In the binding experiments utilizing the Flag M2 antibody, the probe and oligomer were mixed before the addition of the antibody.
Construction of chloramphenicol acetyltransferase (CAT) vectors
The ligation of the PEPCK promoter from -490 to + 73 to the CAT reporter gene has been described [12] . Mutations in the TRE (-330/ -313) of the PEPCK promoter were introduced by two-step PCR amplification [29] . In the initial PCR, one outside primer representing either -490 to -470 or + 73 to + 53 in the PEPCK promoter and an internal primer from -333 to -308 which hybridized to a second strand and contained the 4 bp mutation were used to amplify a fragment of the PEPCK nucleotides and overlapped in the 20 bp region from -330 to -310. The DNA segments were purified from the primers, mixed and amplified again using the outside primers. The DNA product contained the entire PEPCK promoter from -490 to + 73 and was ligated in front of the CAT reporter gene in XbaI and BgiII sites. The promoter containing each mutation was sequenced with Sequenase II (USB) to confirm its identity. The sequences of the top strand of the oligomers used to create the vectors with mutations in the -330 to -310 region are given: PTREM329-326 ccctactattgacccccacctgac, PTREM323-320 cctgtccttactacccacctgac, PTREM317-314 cctgtccttgaccccactatgac, PTREM328-320 cccggtaaccataccccacctgac, PTREM320-311 ccctgttccttgacataggtaaccc. The nucleotides in the P3(I) region were altered by the PCR-based strategy. The sequences of the primers on the top strand are given: P3M235-32 aaacgttgtgtaactgatcaactatg and P3M248-7/42-1 tcttacgtcatgtaaggactc.
Cell transfecUons and CAT assays
HepG2 cells were transfected by calcium phosphate precipitation as described previously [10, 12] . Each transfection mixture . To determine if these repeats were involved in the induction of PEPCK transcription by T3, a 4 bp mutation was introduced into the GGTC core of each of the repeats. These mutations were performed in the context of the full-length PEPCK promoter extending from -490 to + 73 because the induction by T3 is greater from the intact promoter than from a neutral promoter to which the -332 to -308 region has been ligated [10] . The promoters containing these mutations were ligated to the CAT reporter gene. These PEPCK-CAT vectors were co-transfected with an expression vector for the TR/8 into HepG2 cells and exposed to T3. The cells were harvested and the CAT activity assessed.
Transcription from the wild-type PEPCK-CAT vector was increased threefold by the addition of T3 in the transienttransfection experiments ( Figure Ib ). This stimulation corresponds to the previously reported effects of T3 on PEPCK transcription in vivo [4] . The PEPCK-CAT vector, PTREM329-326, in which the 5'-most repeat was disrupted, was unable to respond to T3. Likewise, PTREM323-320 was not induced by T3. However, T3 stimulated transcription of the PEPCK-CAT vector, PTREM317-314, in which the 3'-most repeat was altered, indicating that this sequence was not involved in the T3 response. Two broad mutations were also tested. The next experiments examined whether other proteins in rat liver nuclear extract could bind to PEPCK-TRE. A gel mobility assay was conducted using the 32P-labelled PEPCK-TRE oligomer and rat liver nuclear extract (Figure 4a ). Two complexes were formed between rat liver nuclear extract and PEPCK-TRE, one of which migrated in a similar fashion to the TR,-RXRac heterodimer. Several groups have demonstrated that nuclear extract will enhance the binding ofTR to TREs [21, 25] . Therefore we tested whether rat liver nuclear extract would improve the binding of TR,? to PEPCK-TRE (Figure 4b were used that did not form detectable complexes in gel mobility assays. When both TR,8 and rat liver nuclear extract were added to the reaction mixture, two additional complexes were formed. These complexes could be supershifted or disrupted by the addition of an antibody to TR/3. No complexes were formed when TRfl antibody and rat liver nuclear extract were added to the reaction mixture. These results demonstrate that a protein, which is probably the RXR in rat liver nuclear extract, enhances the binding of TRf to PEPCK-TRE.
To characterize further the binding of proteins from rat liver nuclei to PEPCK-TRE, a competition analysis was conducted using rat liver nuclear extract, PEPCK-TRE and unlabelled competitor oligomers ( Figure 5 ). The oligomer, Mut 329-326, competed for the binding of rat liver nuclear extract to PEPCK-TRE, whereas Mut 323-320 was not an effective competitor, indicating that these nucleotides were involved in the binding of this protein. The protein(s) in rat liver nuclear extract had a different binding specificity for PEPCK-TRE from that of the TRfl-RXRa heterodimer. These data indicate that, in addition to TR and RXR, there is an another protein present in rat liver nuclei which will bind to PEPCK-TRE.
Identification of additional sites required for T3 action In addition to the CRE, several adjacent elements including P3(I) (-250/234), P3(11) (-260 to -250) and P4 (-285 to -270) are required for the full induction of PEPCK transcription cAMP [11] . These elements contain binding sites for C/EBP and Fos/Jun [12, 30] . The P3(I) site is also involved in the stimulation of PEPCK transcription by T3 [10] . To determine whether P3(II) or P4 were required for the induction of PEPCK transcription by T3, transient transfections with PEPCK-CAT vectors containing mutations in these elements of the promoter were conducted.
Disruption of the P3(II) or P4(I) binding sites did not block the T3 effect (Figure lc) . These results suggest that there is a specific interaction between the proteins bound to the P3(I) element and the TRE.
As the P3(I) site is required for T3 induction, the possibility that TR, could bind to P3(I) was examined. In gel mobility To determine whether the binding of a C/EBP or TR/J at the P3(I) site was required for T3 stimulation of PEPCK transcription, the mutations contained in the oligomers used in Figure 6 were introduced into the PEPCK-CAT vector, and these constructs transiently transfected into HepG2 cells ( Figure  Id) . T3 stimulated transcription of the vector P3M235-232, in which the TRfl-binding site was disrupted. This result indicates that T3 induction does not require TR, to be bound to P3(I). The P3M248-242 vector in which the C/EBP site is disrupted does not respond to T3. Introduction of a CREB-binding site (P3M248-247/242-241) also eliminated T3 responsiveness. These observations suggest that the T3 response involves specific interactions between a C/EBP bound to the P3(I) site and TR, bound to PEPCK-TRE.
DISCUSSION
T3affects the hepatic pathways of glucose and lipid metabolism by increasing the activity of enzymes such as glucokinase, fatty acid synthetase and carnitine palmitoyltransferase-I as well as gluconeogenic enzymes such as PEPCK [1, 4, 31, 32] . In Interestingly, the retinoic acid response element in the PEPCK promoter does not follow the 3-4-5 rule and consists of a DRI [8] . To our knowledge, PEPCK-TRE is the first natural TRE to be described consisting of direct repeats which mediates a T3
response and further emphasizes that a variety of elements are able to confer T3 responsiveness. It was reported that TR will protect a 30 bp region of the PEPCK promoter from -324 to -294 in DNase I footprinting assays [33] . This region partially overlaps the functional TRE (-330 to -319) defined in this study. In our gel mobility assays, none of the 4 bp mutations in the -330 to -313 region completely eliminated the ability of TR to bind to PEPCK-TRE in gel mobility assays (results not shown). Because the -330 to -294 region contains several AGGTCA-like motifs, TR may be able to bind in several different conformations in the in vitro binding assays. However, only the nucleotides between -330 and -319 are essential for T3 stimulation of transcription.
Previous studies using a variety of TREs have shown that TR binds far more effectively in the presence of rat liver nuclear extract [21, 25] . This enhancement is probably due to the heterodimerization of TR with RXR present in the nuclear extract, although the possibility that other proteins might be involved cannot be excluded. Our experiments demonstrate directly that TR,J will bind to PEPCK-TRE more effectively when present as a heterodimer with RXR ( Figure 2) and that TRfl will form a heterodimer with a protein present in rat liver nuclei (Figure 4b ). Using the -332 to -308 oligomer in gel mobility assays with subsequent Scatchard analysis, we determined a Kd of 2 nM for the binding of TRfl and RXRa (results not shown). Affinity determinations of the binding of TR alone and in the presence of rat liver nuclear extract to the PEPCK promoter were made using the avidin-biotin complex DNA assay and a similar Kd of 4 nM was obtained for the combination of TR and rat liver nuclear extract [33] . Schmidt et al. [33] also reported that the affinity of TR and of the heterodimer of TR and rat liver nuclear extract was identical but that the capacity of TR binding was far greater in the presence of rat liver nuclear extract. Our results in combination with these previous observations suggest that in vivo TR/ will probably bind to PEPCK-TRE as a heterodimer with RXR. We determined that another protein present in rat liver nuclei will also bind to PEPCK-TRE although not to the key nucleotides for TRfl binding. As might be expected given the complex regulation of PEPCK gene expression, many elements in the PEPCK promoter such as CRE or the accessory factor 1 (AFI) sites have the ability to bind several proteins present in the nuclear extract [13, 34] .
TR has been shown to bind to three sites within the PEPCK promoter including the AFI site (-450 to -435) [35] , P3(I) and TRE. The AFI site is essential for the induction of PEPCK transcription by glucocorticoids and retinoic acid [7, 8] , but does not contribute to T3 stimulation of PEPCK transcription, as serial deletions of the PEPCK promoter that remove this sequence did not eliminate T3 induction [10] . However, the AFI site binds RAR, RXR, hepatic nuclear factor 4, PPAR and other unidentified proteins present in rat liver nuclear extract [8, 34, 36] . Since TR binds poorly to a direct repeat spaced by one nucleotide, it is more likely that this site will be bound by the high-affinity RAR-RXR or PPAR-RXR heterodimers or one of the other.
proteins present in the liver nuclei. Although TR,? can also bind to the P3(I) site, our experiments clearly show that the binding of TR to the P3(I) element is not necessary for T3 response ( Figure  6 ). Therefore only the binding of TR to TRE (-330 to -319) contributes to T3 induction.
The P3(I) site plays a central role in liver-specific expression and cAMP responsiveness of the PEPCK gene [11, 4] . Transgenic mice containing a chimaeric gene with the PEPCK promoter driving bovine growth hormone gene express high levels of the transgene in the liver, but mice containing this chimaeric gene with a mutated P3(I) site have reduced hepatic expression [14] . Only members of the C/EBP family and D-site-binding protein can bind to this site [13, 37] . The P3(I) site also has a critical role in T3 responsiveness. There have been previous reports of TR interacting with proteins bound to other sites in the promoter. Schaufele et al. [38] found that there was synergistic activation of transcription from the rat growth hormone promoter by TR and Pit-i transcription factor [38] . Interestingly, this synergism was independent of T3. Voz et al. [39] demonstrated interactions between TR and Pit-I on the human placental lactogen B promoter. These binding sites were immediately adjacent and the interaction diminished in a distance-dependent manner. In addition, the replacement of the Pit-I recognition sequence with that of other nuclear factors did not eliminate the synergistic interaction. The interaction between the proteins bound to TRE and the P3(I) sites in the PEPCK promoter is unique in that it is ligand-dependent and that the binding sites are separated by 80 bp. It has been shown that C/EBPa can stimulate transcription through both the CRE and P3(I) sites [11] . However, C/EBP/3 enhances PEPCK transcription only through the CRE even though it binds the P3(I) site [13] . These observations suggest that TR may interact with C/EBPo or another member of the C/EBP family rather than C/EBP,8.
